Samsara Vision
Samsara Vision is a medical device company focused on advancing treatments for serious retinal diseases through innovative ophthalmic implant technologies. The company is developing solutions designed to address significant unmet needs in patients with advanced retinal degeneration, where existing therapeutic options are limited.
Caresyntax
Caresyntax offers AI-powered software, devices, and clinical services designed to enhance surgical outcomes. With a significant global presence in operating rooms, their technology has been utilized in millions of surgeries and boasts a substantial user base of surgical professionals.
NETTWORK HOLDINGS
Nettwork Holdings is a distribution focused company that supports commercialization efforts across the healthcare ecosystem.
Ansella Therapeutics
Ansella Therapeutics is specialty pharmaceutical company that leverages biomimetic sciences to develop novel therapeutics that improve healthcare outcomes. The company’s initial focus is on women’s health, specifically in the development of novel vaginal formulations.
Enquyst Technologies
Enquyst Technologies is developing the next-generation biopharmaceutical manufacturing platform which aims to redesign the downstream bioprocess equipment to bring unprecedented advantages in cost, time, footprint, and speed to market at commercial scale.
Endeavor Biomedicines
Endeavor’s ENV-101 is a second-generation Hedgehog inhibitor with a highly favorable efficacy and side-effect profile compared to the molecules currently in the market. ENV-101 inhibits target pathway by ~90% at all tested doses.
PTO
An athlete-owned entity that supports non-drafting professional triathletes, the PTO is unique as a professional sports organisation in representing both pro women and men and through our athletes being self-determined co-owners.
Avive Solutions
Avive is a MedTech company that has developed a next-generation automated external defibrillator (AED) and software solutions that revolutionizes the current sudden cardiac arrest (SCA) response.